Jeffrey Kutner
Senior Director - Planning and Analysis at Xalud Therapeutics, Inc. - New York, NY, US
Jeffrey Kutner's Colleagues at Xalud Therapeutics, Inc.
Jeffrey Kutner's Contact Details
212-301-6673
New Jersey,United States
Xalud Therapeutics, Inc.
Jeffrey Kutner's Company Details
Xalud Therapeutics is a biotechnology company developing a non-viral gene therapy platform to treat pathologic inflammation through immune modulation. The company is harnessing the power of interleukin-10 (IL-10), a potent cytokine that acts as a master regulator for multiple inflammatory pathways, to address the root cause of inflammation and subsequently restore homeostasis in the immune system. Xalud's lead product candidate, XT-150, is a locally injectable plasmid DNA gene therapy expressing IL-10 to addresses pathologic inflammation and pain.